Correlation Engine 2.0
Clear Search sequence regions


  • anesthesia (1)
  • benzamides (2)
  • carbachol (1)
  • ether (1)
  • evans blue (1)
  • humans (1)
  • impairment (1)
  • ischemia (2)
  • NK1 (6)
  • NK1 receptor (1)
  • NK2 (5)
  • piperidines (2)
  • quinolines (2)
  • quinuclidines (2)
  • rats (5)
  • receptor (3)
  • receptors tachykinin (2)
  • sb 222200 (1)
  • SB222200 (2)
  • sham (4)
  • sr 140333 (1)
  • sr48968 (3)
  • tachykinin (4)
  • transit (2)
  • Sizes of these terms reflect their relevance to your search.

    Supraceliac aortic clamping and unclamping produces ischemia-reperfusion (I/R) injury of the splanchnic organs. The protective effects of tachykinin receptor antagonists, SR140333 (NK1 receptor), SR48968 (NK2 receptor), and SB222200 (NK3 receptor), against I/R-induced inhibition of intestinal motility were tested in rats. The intestinal transit of Evans blue was measured in untreated rats and animals subjected to skin incision, I/R (1 h superior mesenteric artery occlusion followed by 24 h reperfusion) or sham operation. Surgical procedures were conducted under diethyl ether anesthesia. The gastrointestinal transit has not been markedly affected in rats, which were anesthetized or subjected to skin incision in comparison with untreated animals. In contrast, a sham operation and I/R have significantly reduced the intestinal motility. Pretreatment with NK1-3 blockers (SR140333 [3-30 μg/kg]; SR48968 [3-100 μg/kg]; and SB222200 [10-100 μg/kg]) reversed dose dependently the effects of I/R to the level observed after sham operation only. A combination of NK1+NK2+NK3 inhibitors exerted an additive effect compared with NK1 and NK2 antagonists used as single agents. Similarly, combined NK1+NK2 were more effective than NK2 alone. Sham operation and I/R have shifted the in vitro carbachol concentration-response curves to the right in comparison with untreated animals, a phenomenon partially reversed by NK1-NK3 pretreatment. Single-agent and combined treatment with NK1-3 antagonists markedly attenuated the gastrointestinal dysmotility evoked by I/R injury. The pretreatment with NK3 blocker proved to be the most active in this experimental setting. Copyright © 2020 Elsevier Inc. All rights reserved.

    Citation

    Artur Umer, Hanna Ługowska-Umer, Oliver Schönborn-Kellenberger, Paweł K Korolkiewicz, Łukasz Sein-Anand, Krzysztof Kuziemski, Roman P Korolkiewicz. Tachykinin Antagonists Reverse Ischemia/Reperfusion Gastrointestinal Motility Impairment in Rats. The Journal of surgical research. 2020 Nov;255:510-516

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32629333

    View Full Text